-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Alx Oncology Holdings Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
- Alx Oncology Holdings Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $5.86M, a 12.8% decline year-over-year.
- Alx Oncology Holdings Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $27.1M, a 3.12% increase year-over-year.
- Alx Oncology Holdings Inc annual Share-based Payment Arrangement, Expense for 2024 was $27.1M, a 3.12% increase from 2023.
- Alx Oncology Holdings Inc annual Share-based Payment Arrangement, Expense for 2023 was $26.3M, a 10.2% increase from 2022.
- Alx Oncology Holdings Inc annual Share-based Payment Arrangement, Expense for 2022 was $23.8M, a 71.3% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)